Physician profile
Carl Speer
NPI 1699127142
$7,649.49
in general payments reported to CMS, 2019-2025
19 companies · $175 in 2025
The $175 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,616 · 2020: $60.66 · 2021: $55.00 · 2022: $4,194 · 2023: $330 · 2024: $219 · 2025: $175.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $724.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $724.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cgg Medical INC | $2,400.00 | 2022 | |
| Mid-Atlantic Surgical Systems, LLC | $2,258.84 | 2019 | |
| Stryker Corporation | $1,700.90 | 2022-2025 | Ortholoc 3di, Anchorage |
| Paratek Pharmaceuticals, INC. | $294.09 | 2022-2024 | Nuzyra |
| Smith+Nephew, INC. | $235.27 | 2021-2024 | Collagenase Santyl, Regranex |
| Horizon Therapeutics Plc | $132.11 | 2019 | |
| Depuy Synthes Sales INC. | $123.97 | 2019-2024 | Motoband |
| Celgene Corporation | $120.27 | 2023-2024 | Zeposia |
| Medline Industries LP | $118.36 | 2019 | |
| Zimmer Biomet Holdings, INC. | $60.66 | 2020 | |
| Nevro Corp. | $43.00 | 2022 | |
| Fidia Pharma USA INC. | $39.91 | 2021 | |
| Cardiovascular Systems INC. | $24.37 | 2022 | |
| Zimvie INC. | $20.20 | 2023 | |
| Abbott Laboratories | $18.78 | 2025 | Eterna |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $16.71 | 2023 | Dalvance |
| Orthofix Medical, INC. | $15.52 | 2022 | |
| Kci USA, INC. | $13.55 | 2023 | V.A.C. Veraflo, V.A.C. Dermatac, Express |
| Kowa Pharmaceuticals America, INC. | $12.98 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carl Speer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.